Company: NEWTP
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001628280-25-050582
Chunk: 41

Company: NewtekOne, Inc.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
 $3,108 $40,227 $45,166 $1,270 $28 $24,747 $26,045 1    Excludes $3 thousand and $218 thousand of Provision for credit losses relating to unfunded commitments for the three months ended September 30, 2025 and 2024, respectively, which is recorded within Accounts payable, accrued expenses and other liabilities in accordance with ASC 326.

The Company identified 383 and 145 loans as of September 30, 2025 and December 31, 2024, respectively, that did not share similar risk characteristics with the loan segments identified in NOTE 2—SIGNIFICANT ACCOUNTING POLICIES and evaluated them for impairment individually. The following table presents the individually evaluated and collectively evaluated ACL by segment:September 30, 2025December 31, 2024ACLCREC&ISBATotalCREC&ISBATotalIndividually Evaluated$— $1,536 $12,788 $14,324 $— $— $7,019 $7,019 Collectively Evaluated1,831 1,572 27,439 30,842 1,430 315 21,469 23,214 Total$1,831 $3,108 $40,227 $45,166 $1,430 $315 $28,488 $30,233 The following table presents the recorded investment in loans individually evaluated and collectively evaluated by segment:September 30, 2025December 31, 2024Recorded InvestmentCREC&ISBATotalCREC&ISBATotalIndividually Evaluated$18,824 $2,465 $60,048 $81,337 $2,635 $— $21,706 $24,341 Collectively Evaluated238,097 62,422 449,864 750,383 189,196 47,558 359,275 596,029 Total$256,921 $64,887 $509,912 $831,720 $191,831 $47,558 $380,981 $620,370 

F-35

The amortized cost basis of loans on nonaccrual status and the associated ACL are as follows:September 30, 2025December 31,